Juno Research LLC - Medical Center

Houston, Texas 77054

1 studies enrolling now · 1 studies all time

What they study most

Lipidemia, Metabolic Syndrome (MetS), Type 2 Diabetes (T2DM)

Studies at this site

• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Recruiting now